Unexpectedly, the lower tofacitinib dosage arm showed a trend toward the lowest rejection rate and a superior allograft function.
1
—
—
Unexpectedly, the lower tofacitinib dosage arm showed a trend toward the lowest rejection rate and a superior allograft function.